Sonoma Pharmaceuticals (SNOA) Share-based Compensation: 2011-2025
Historic Share-based Compensation for Sonoma Pharmaceuticals (SNOA) over the last 14 years, with Mar 2025 value amounting to $224,000.
- Sonoma Pharmaceuticals' Share-based Compensation fell 55.65% to $204,000 in Q1 2013 from the same period last year, while for Mar 2013 it was $1.2 million, marking a year-over-year decrease of 55.48%. This contributed to the annual value of $224,000 for FY2025, which is 56.59% down from last year.
- According to the latest figures from FY2025, Sonoma Pharmaceuticals' Share-based Compensation is $224,000, which was down 56.59% from $516,000 recorded in FY2024.
- In the past 5 years, Sonoma Pharmaceuticals' Share-based Compensation registered a high of $669,000 during FY2023, and its lowest value of $224,000 during FY2025.
- Over the past 3 years, Sonoma Pharmaceuticals' median Share-based Compensation value was $516,000 (recorded in 2024), while the average stood at $469,667.
- Per our database at Business Quant, Sonoma Pharmaceuticals' Share-based Compensation surged by 75.13% in 2023 and then crashed by 56.59% in 2025.
- Sonoma Pharmaceuticals' Share-based Compensation (Yearly) stood at $371,000 in 2021, then grew by 2.96% to $382,000 in 2022, then soared by 75.13% to $669,000 in 2023, then dropped by 22.87% to $516,000 in 2024, then plummeted by 56.59% to $224,000 in 2025.